1.
Sesquiterpene lactones: Adverse health effects and toxicity mechanisms
by Amorim, M. Helena R
Critical reviews in toxicology, 2013-08, Vol.43 (7), p.559-579

2.
Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications
by Touchefeu, Y.
Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (5), p.409-421

3.
Rapid translocation of nanoparticles from the lung airspaces to the body
by Bawendi, Moungi G
Nature biotechnology, 2010-12, Vol.28 (12), p.1300-1303

4.
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis
by SHUBBER, Zara
AIDS (London), 2013, Vol.27 (9), p.1403-1412

5.
Review article: herbal hepatotoxicity – an update on traditional Chinese medicine preparations
by Teschke, R.
Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (1), p.32-50

6.
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
by Fellay, Jacques
The Lancet (British edition), 2001, Vol.358 (9290), p.1322-1327

7.
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program
by Armstrong, M. J.
Alimentary pharmacology & therapeutics, 2013-01, Vol.37 (2), p.234-242

8.
Diagnosis, management and prevention of drug-induced liver injury
by Verma, S
Gut, 2009-11, Vol.58 (11), p.1555-1564

9.
Olmesartan‐associated enteropathy: results of a national survey
by Marthey, L.
Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.1103-1109

10.
Triclosan: A critical review of the experimental data and development of margins of safety for consumer products
by Rodricks, Joseph V
Critical reviews in toxicology, 2010-05, Vol.40 (5), p.422-484

11.
Chemotherapy-induced peripheral neuropathy
by QUASTHOFF, Stefan
Journal of neurology, 2002, Vol.249 (1), p.9-17

12.
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
by Sánchez-González, Penélope D
Critical reviews in toxicology, 2011-11, Vol.41 (10), p.803-821

13.
Systematic review: sprue‐like enteropathy associated with olmesartan
by Ianiro, G.
Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (1), p.16-23

14.
Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity
by YOMBI, Jean C
AIDS (London), 2014, Vol.28 (5), p.621-632

15.
Hepatotoxicity: A scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action
by Hewitt, M
Critical reviews in toxicology, 2013-08, Vol.43 (7), p.537-558

16.
European guidelines on managing adverse effects of medication for ADHD
by Graham, J
European child & adolescent psychiatry, 2011, Vol.20 (1), p.17-37

17.
The Neuropsychiatric Complications of Glucocorticoid Use: Steroid Psychosis Revisited
by Dubovsky, Amelia N., M.D
Psychosomatics (Washington, D.C.), 2012, Vol.53 (2), p.103-115

18.
Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
by Deepak, P.
Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (4), p.388-396

19.
Potential Ecological and Human Health Risks Associated With the Presence of Pharmaceutically Active Compounds in the Aquatic Environment
by Jones, O. A. H
Critical reviews in toxicology, 2004, Vol.34 (4), p.335-350

20.
Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone
by Ott, Michael C
Chest, 2003-02, Vol.123 (2), p.646-651
